#pharma 

By this increase in prices of #API #ksm from pre #Covid_19 prices will lead to Indian Pharma producing their own requirements 
Can be a big boost to the domestic players after a temporary dent.

#StockMarket #stocks #China #pharma20 #market https://t.co/SaE0odX12E